월경곤란증 검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 치료법별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Dysmenorrhea Testing Market size was valued at USD 3.89 Billion in 2024 and is poised to grow from USD 4.21 Billion in 2025 to USD 7.84 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global dysmenorrhea testing market is experiencing significant growth driven by the increasing prevalence of dysmenorrhea, heightened awareness surrounding menstrual health, and advancements in diagnostic technologies. As more individuals face menstrual pain, there is a surge in demand for clinical evaluations and testing services. Supportive government policies promoting funding for menstrual health research and national screening initiatives have further improved access to dysmenorrhea testing. The rise of reproductive health clinics and awareness around fertility has amplified testing opportunities. Innovations such as artificial intelligence, machine learning, and IoT are transforming diagnostics by enabling data analysis of symptoms and patterns, while augmented and virtual reality are enhancing clinician training. This convergence of technology and awareness is shaping the future landscape of dysmenorrhea testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dysmenorrhea Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dysmenorrhea Testing Market Segments Analysis

Global Dysmenorrhea Testing Market is segmented by Product Type, Type of Treatment, End User and region. Based on Product Type, the market is segmented into Primary Dysmenorrhea Testing and Secondary Dysmenorrhea Testing. Based on Type of Treatment, the market is segmented into Pain Relievers, Hormonal Therapy and Surgery. Based on End User, the market is segmented into Hospitals and Clinics and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dysmenorrhea Testing Market

The rising prevalence of both primary and secondary dysmenorrhea has led to an increased demand for clear diagnostic solutions, as more women actively seek medical assistance for chronic or intense menstrual pain. This growing awareness has heightened the necessity for dysmenorrhea testing. Additionally, the efforts of governments and non-governmental organizations promoting women's health have further stimulated the importance of medical screenings for menstrual disorders. As a result, the combination of heightened health awareness and advocacy initiatives is driving the expansion of the Global Dysmenorrhea Testing market.

Restraints in the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market faces significant challenges rooted in cultural perceptions surrounding menstruation, which often view it as a source of shame. This stigma not only hampers open discussion but also restricts access to essential menstrual health services. In more conservative communities, women frequently encounter barriers that prevent them from prioritizing their health, particularly when experiencing painful symptoms that are commonly dismissed. Furthermore, even when patients communicate their experiences, healthcare providers may neglect to pursue further investigation due to inherent gender biases, ultimately impacting diagnosis and treatment for dysmenorrhea. Such societal factors contribute to the overall restraints in the market.

Market Trends of the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market is experiencing a significant upward trend driven by increasing awareness and the normalization of menstrual health discussions. Educational initiatives spearheaded by governments and nonprofit organizations are effectively breaking stigmas associated with menstrual pain, prompting more women to pursue dysmenorrhea testing and related healthcare services. This heightened awareness is fueling demand for advanced testing solutions, including hormonal profiling, ultrasounds, and innovative deep learning imaging techniques, which allow for personalized assessments. As women seek informed care options, the market is poised for growth, reflecting broader health trends focused on women's reproductive health and well-being.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Dysmenorrhea Testing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Primary Dysmenorrhea Testing
• Secondary Dysmenorrhea Testing

Global Dysmenorrhea Testing Market Size by Type of Treatment & CAGR (2026-2033)

• Market Overview
• Market Overview
• Pain Relievers
• Hormonal Therapy
• Surgery

Global Dysmenorrhea Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Research Centers

Global Dysmenorrhea Testing Market Size & CAGR (2026-2033)

• North America (Product Type, Type of Treatment, End User)
  • US
  • Canada
• Europe (Product Type, Type of Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type of Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type of Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type of Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Pharma plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations